Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.
A deadly disease and modern pharmacological attempts to treat it.
Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.